Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Update
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Comment by jopatcloon Oct 27, 2024 2:20pm
44 Views
Post# 36284090

RE:RE:RE:RE:RE:RE:Update

RE:RE:RE:RE:RE:RE:UpdateInteresting Benjamin Joas Rieck see in this photo   Team Connection at Ventripoint: A Meeting to Remember! and now  Big News from AngioConsult! 

We're excited to announce that Benjamin Joas Rieck is set to take the stage at TCT2024 in Washington, D.C.! 
No alternative text description for this image
Big News from AngioConsult!

We're excited to announce that Benjamin Joas Rieck is set to take the stage at TCT2024 in Washington, D.C.! Catch his session on "A Living Endogenous Patient-Specific TAVR System (GrOwnValve)" on Monday, October 28th at 11:00 AM in the Innovation Theater.

This is your chance to dive into the future of cardiovascular technology with a presentation that promises to be as insightful as it is revolutionary.

Save the date! Come connect with us and explore groundbreaking advancements in cardiology.

TCT2024 TCT AngioConsult HealthTech Innovation Cardiology TAVR

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities